Funding Opportunity PAR-20-294 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) encourages grant applications for support of the core functions of Cancer Epidemiology Cohorts (CECs), as well as methodological research. This FOA is intended to support maintenance of existing CECs infrastructure and resource sharing with broader scientific communities.

Notice NOT-GM-20-050 from the NIH Guide for Grants and Contracts

Notice NOT-LM-20-015 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-20-286 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for research centers to support integrated programs of high-impact, practice-based research with near-term potential to address NIMH suicide prevention priorities and help achieve the National Action Alliance for Suicide Prevention goals of reducing the rate of suicide in the US. The Centers are intended to support transdisciplinary teams of clinical and mental health services researchers, behavioral/social scientists, health information and communications technologists, health systems engineers, decision scientists, and mental health stakeholders (e.g., service users, family members, clinicians, payers) engaged in transdisciplinary programs of research that could not be achieved using standard research project grant mechanisms. Research Centers will support the rapid development, refinement, and testing of effective and scalable approaches for intervening at key intercepts in the chain of care: for identifying high-risk individuals, for promoting continuity across key care transitions (e.g., following identification in the emergency department or discharge from inpatient care), and for intervening (including prevention strategies and treatment for acute risk)

Notice NOT-AG-20-038 from the NIH Guide for Grants and Contracts

Notice NOT-AT-20-016 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-157 from the NIH Guide for Grants and Contracts

Notice NOT-GM-20-049 from the NIH Guide for Grants and Contracts

Notice NOT-NS-20-095 from the NIH Guide for Grants and Contracts

Notice NOT-DE-20-029 from the NIH Guide for Grants and Contracts

Can identify opportunities for efficiency improvements and simplification, recognizes appropriate resources for deliverables, has effective organizational…
From Seattle Genetics - Wed, 05 Aug 2020 00:14:45 GMT - View all Bothell, WA jobs

Experience in processing, QC, and downstream analysis of RNA sequencing data (e.g. Experience in processing, QC, and downstream analysis of DNA sequencing data …
From University of Wisconsin–Madison - Tue, 04 Aug 2020 00:58:07 GMT - View all Madison, WI jobs

Funding Opportunity RFA-HD-21-026 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to form Centers of Excellence in Therapeutics (CETs) as part of the NICHDs Maternal and Pediatric Precision in Therapeutics (MPRINT) Hub. The MPRINT Hub will serve as a national resource for expertise in maternal and pediatric therapeutics to conduct and foster therapeutics-focused research in obstetrics, lactation, and pediatrics while enhancing inclusion of people with disabilities. By serving as a national resource, it will aggregate, present, and expand the available knowledge, tools, and expertise in maternal and pediatric therapeutics to the broader research, regulatory science, and drug development communities. The MPRINT CETs will work together and with the MPRINT Knowledge and Research Coordination Center (KRCC; RFA-HD-21-025), the central coordinating center of the MPRINT Hub, to serve as a national resource for knowledge and expertise in maternal and pediatric pharmacology and as a research center to close deficits in knowledge and technical expertise. The MPRINT CETs will conduct cutting edge clinical, translational, basic, and/or data sciences research, provide resources, and generate novel tools and approaches to advance and accelerate research and regulatory science in maternal and pediatric therapeutics. The MPRINT KRCC will serve as the primary public-facing component of the MPRINT Hub and as a conduit to the resources of the MPRINT CETs.

Funding Opportunity RFA-HD-21-025 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to form the Knowledge and Research Coordination Center (KRCC) of the NICHDs Maternal and Pediatric Precision in Therapeutics (MPRINT) Hub. The MPRINT Hub will serve as a national resource for expertise in maternal and pediatric therapeutics to conduct and foster therapeutics-focused research in obstetrics, lactation, and pediatrics while enhancing inclusion of people with disabilities. By serving as a national resource, it will aggregate, present, and expand the available knowledge, tools, and expertise in maternal and pediatric therapeutics to the broader research, regulatory science, and drug development communities. The MPRINT KRCC will coordinate and support the operations of the entire MPRINT Hub, interface with Centers of Excellence in Therapeutics (CETs; RFA-HD-21-026), and develop a web portal to access an underlying curated knowledge base of maternal and pediatric pharmacology and therapeutics. This knowledge base will aggregate and identify knowledge deficits in the principles of maternal and pediatric therapeutics including pharmacokinetics, pharmacodynamics, genetics, proteomics, and metabolomics that inform drug development and regulatory science. The MPRINT KRCC will serve as the primary administrative component and public-facing component of the MPRINT Hub as well as a conduit to the resources in its other components such as the MPRINT CETs. Additionally, the MPRINT KRCC will oversee an Opportunity Pool of funds to address emergent needs in support of national research in maternal and pediatric therapeutics.

F. Hoffmann-La Roche AG: Are you ready for your next challenge?At Roche, we believe it’s urgent to deliver medical solutions right now – even as we develop innovations for th Switzerland (CH)

GBP35000.00 - GBP45000.00 per annum: SRG: My client is an innovative, dynamic and rapidly growing Biotechnology company based in Wales Cardiff, Wales

GBP35000.00 - GBP45000.00 per annum: SRG: My client is an innovative, dynamic and rapidly growing Biotechnology company based in Wales Cardiff, Wales

Competitive: Joint Genome Institute: Berkeley Lab’s Joint Genome Institute (https://jgi.doe.gov/) has an opening for a Research Scientist to join the Sequencing California

Radcliffe fellows receive a stipend of $78,000 plus an additional $5,000 to cover project expenses.: Radcliffe Institute for Advanced Study: Applications for the 2021-2022 Fellowship | Radcliffe Institute for Advanced Study at Harvard University Cambridge, Massachusetts

Notice NOT-AG-20-040 from the NIH Guide for Grants and Contracts